Pain Medication Data from the 2021 and 2022 National Football League Prescription Drug Monitoring Program.

Autor:	Hill KP, Kroenke K; Indiana University School of Medicine and Regenstrief Institute, Indianapolis, IN., Wasserman EB; IQVIA, Research Triangle Park, NC., Mack C; IQVIA, Research Triangle Park, NC., Ling GSF, Mayer T; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD., Solomon GS, Sills A
Jazyk:	angličtina
Zdroj:	Current sports medicine reports [Curr Sports Med Rep] 2024 Oct 01; Vol. 23 (10), pp. 348-351. Date of Electronic Publication: 2024 Oct 01.
DOI:	10.1249/JSR.0000000000001200
Abstrakt:	Abstract: We report 2021 and 2022 prescription drug monitoring program data that include pain medication prescriptions, including over-the-counter medications, issued to NFL players by either club physicians or external medical providers and entered in the NFL electronic medical record. Of 3142 players who signed a contract with at least one NFL Club during the 2021 season, there were 14,903 prescriptions for pain medications issued to 2207 players. During the 2022 season, there were 14,880 prescription pain medications issued to 2189 players (out of a population of 3152). Notably, most pain medication prescriptions across the two seasons were for nonsteroidal anti-inflammatory agents (NSAIDs; 85.1%), whereas only 2.9% were for opioids. Despite the demanding physical nature of professional football and the need for pain management during a season, the prevalence of opioid prescriptions among NFL players appears to be similar to and, in some cases, potentially lower than previous U.S. population-based data. (Copyright © 2024 by the American College of Sports Medicine.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu